First Time Loading...

Stoke Therapeutics Inc
NASDAQ:STOK

Watchlist Manager
Stoke Therapeutics Inc Logo
Stoke Therapeutics Inc
NASDAQ:STOK
Watchlist
Price: 13.685 USD -5.03% Market Closed
Updated: May 28, 2024

EV/EBITDA
Enterprise Value to EBITDA

-4.6
Current
-4.5
Median
4.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-4.6
=
Enterprise Value
534.7m
/
EBITDA
-116m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-4.9
2-Years Forward
EV/EBITDA
-4.2
3-Years Forward
EV/EBITDA
-4.2

See Also

Discover More